Chemed Corporation (NYSE:CHE – Get Free Report) CEO Kevin Mcnamara sold 2,000 shares of the company’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $541.16, for a total transaction of $1,082,320.00. Following the completion of the transaction, the chief executive officer directly owned 70,418 shares of the company’s stock, valued at approximately $38,107,404.88. The trade was a 2.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
Chemed Stock Up 0.2%
Shares of Chemed stock traded up $0.92 during trading on Monday, reaching $541.49. The stock had a trading volume of 21,011 shares, compared to its average volume of 215,475. The company has a market capitalization of $7.08 billion, a price-to-earnings ratio of 27.21, a P/E/G ratio of 2.05 and a beta of 0.51. The stock has a fifty day moving average price of $499.24 and a two-hundred day moving average price of $446.50. Chemed Corporation has a 52 week low of $365.20 and a 52 week high of $557.00. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17.
Chemed (NYSE:CHE – Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating the consensus estimate of $5.60 by $0.46. The firm had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Sell-side analysts predict that Chemed Corporation will post 23.18 EPS for the current fiscal year.
Chemed Increases Dividend
Analyst Ratings Changes
CHE has been the topic of a number of analyst reports. Wall Street Zen upgraded Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Bank of America reiterated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Royal Bank Of Canada lifted their price objective on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Finally, Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, Chemed has a consensus rating of “Hold” and an average target price of $530.75.
Read Our Latest Stock Analysis on CHE
Institutional Trading of Chemed
A number of hedge funds have recently modified their holdings of the stock. California State Teachers Retirement System increased its holdings in shares of Chemed by 45,134.8% during the second quarter. California State Teachers Retirement System now owns 7,613,918 shares of the company’s stock worth $3,546,106,000 after purchasing an additional 7,597,086 shares during the period. Northwestern Mutual Wealth Management Co. increased its stake in Chemed by 2,444,879.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock worth $2,374,667,000 after acquiring an additional 5,549,876 shares during the period. BlackRock Inc. acquired a new position in Chemed in the 2nd quarter valued at $691,290,000. Norges Bank bought a new position in shares of Chemed in the fourth quarter worth $76,067,000. Finally, AQR Capital Management LLC raised its stake in Chemed by 89.2% in the fourth quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock valued at $139,302,000 after purchasing an additional 153,469 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.
Chemed Company Profile
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Recommended Stories
- Five stocks we like better than Chemed
- If Boeing Ramps Up Production, These Suppliers May Win Big
- Marvell Takes a Shot a Broadcom’s Throne With Google Deal
- 5 of the Most-Upgraded Stocks Over the Last Quarter Are All Software Names—Here’s Why
- Aehr Test Systems Soars Again on Latest Orders, Jefferies Eyes Big-Time Upside Ahead
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
